Actavis and Perrigo announced the approval of Guaifenesin/Pseudoephedrine Tablets, the generic version of Reckitt Benckiser’s Mucinex D tablets. Mucinex D combines ...
Perrigo Co. is the marketer and distributor of a new combination guaifenesin and pseudoephedrine HCl extended-release tablets, which are marketed as an alternative to Mucinex D. Perrigo employs about ...
DUBLIN, Jan. 4, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) and its partner Perrigo Company plc (NYSE: PRGO; TASE) announced the launch of combination guaifenesin 600mg and pseudoephedrine HCl 60mg ...
Cold and allergy symptoms can really be bothersome. Sometimes, you just need a little relief. There are several over-the-counter drugs that can help, including Mucinex D. Mucinex D contains two active ...
Drugmaker Granules India has received U.S. Food and Drug Administration approval for its ANDA (abbreviated new drug application) for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release ...
Allergan plc, a global pharmaceutical company, and its partner Perrigo Company plc announced the launch of combination guaifenesin 600mg and pseudoephedrine HCl 60mg extended-release tablets to retail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback